Mounjaro 12.5 mg price: what UK private treatment actually costs

You've reached 12.5 mg: here's why the price looks different from where you started

If you're pricing up the 12.5 mg dose, you've almost certainly been on tirzepatide for several months already. The treatment schedule starts at 2.5 mg, a lower dose whose main job is to let your system adjust before the real therapeutic work begins, and titration happens in staged steps guided by your prescriber. By the time 12.5 mg is clinically appropriate, you're deep into treatment, and the per-pen price at this dose is meaningfully higher than at the starter end of the range.

That matters for budgeting, and it's worth understanding why. Eli Lilly raised its UK list price significantly from 1 September 2025, the highest doses reportedly rose from around £122 to around £330 per four-week pen. Private providers price above list to cover dispensing, pharmacy overheads and clinical infrastructure, so if you're researching Mounjaro 12.5mg price in the UK market since then, figures have generally been reported somewhere between £250 and £375 per month depending on the provider. These figures are widely reported and hedged as typical; your actual quote will depend on who you use.

One quick check worth doing before you commit: look up any online pharmacy on the GPhC's public register. It takes under a minute, and it tells you immediately whether a pharmacy is legitimately registered. If a provider isn't listed, that's a hard stop.

For a fuller breakdown of how pricing varies across the full dose range, our overview of Mounjaro pricing in the UK sets out the context dose by dose.

What the headline price may not include, and why that gap matters at 12.5 mg

The 12.5 mg dose is where some patients discover that the price they were quoted doesn't stretch as far as they assumed. Certain providers charge separately for consultations, prescriptions, delivery or dose-review calls. At lower doses, those add-ons might feel manageable. At 12.5 mg, where the base pen price is already higher, they stack up quickly, so it's useful to look at the 12.5 mg Mounjaro cost in full rather than the headline pen price alone.

It's also worth asking what clinical oversight looks like at this stage. Dose increases to 12.5 mg (and any subsequent repeat at that level) should involve a prescriber actively reviewing your progress, not an automated system ticking a box. The NICE appraisal of tirzepatide (TA1026) is clear that ongoing clinical assessment is part of appropriate use: if weight loss falls below 5% after six months at the highest tolerated dose, continuing treatment should be reviewed. That kind of oversight has to be built into the service you're paying for.

Questions worth asking any provider: is the consultation included? Is delivery free? Is there a separate prescription fee? Is aftercare available if you have questions between doses? At 12.5 mg, those answers shape what your monthly spend actually is, not just the figure next to the pen.

If you'd like to compare how cost structures differ across providers, this page on finding value at 12.5 mg walks through what to look for.

What nume charges, and why we're open about not being the cheapest option

At nume, the price you pay covers everything: the prescriber's consultation, the prescription, the treatment itself, next-working-day tracked delivery by DPD, and aftercare from our clinical team seven days a week. There are no add-on fees and no subscriptions. Every repeat order is looked at fresh by a real prescriber, not auto-renewed.

We don't run discount codes or promotional offers for prescription medicines. We're not the cheapest option on the market, and that's a deliberate position. The margin we don't cut is what funds a GPhC-registered pharmacy, prescribers who personally review every consultation the same day, and a supply chain that sources medicine through authorised Eli Lilly channels. You can verify our pharmacy registration (number 9012878) on the GPhC register directly.

Current treatment pricing, including the 12.5 mg tier, is shown transparently on our treatment page, no quote request needed.

Our prescribers and the thinking behind our clinical approach are outlined on our clinical team page if you'd like to know more about who reviews your case.

For a prescription medicine, price is the wrong starting question

The MHRA has warned repeatedly about fake weight-loss pens circulating online and via social media, some seized pens have contained insulin rather than tirzepatide, and in October 2025 the first illicit UK manufacturing site producing counterfeit tirzepatide pens was raided. Sellers offering Mounjaro without a clinical assessment, at prices significantly below the market range, or through unverifiable channels are a serious safety concern. If you want a reliable reference point before approaching any provider, our page covering the Mounjaro injection 12.5 mg price explains what a legitimate quote should typically look like.

The NHS guidance on tirzepatide on the NHS website sets out clearly that this is a prescription medicine with a clinical titration process, 12.5 mg is not a starting point, and reaching it safely requires a prescriber who knows your history. At that stage of treatment, the right question isn't which provider is cheapest, and if you're still working out how much 12.5 mg Mounjaro is from a reputable source, that page gives you a grounded starting point before you compare providers. It's which provider can demonstrate genuine clinical oversight, a registered pharmacy, and a verified supply chain.

If you're ready to check whether 12.5 mg is the right step for you, or if you're considering starting treatment and want to understand the full dose journey, start a free consultation and a prescriber will review your case the same day. There's no obligation, and our FAQs cover the most common questions about the process if you'd prefer to read first.